News
CNTB
0.6772
+1.79%
0.0119
Weekly Report: what happened at CNTB last week (1102-1106)?
Weekly Report · 4d ago
Weekly Report: what happened at CNTB last week (1026-1030)?
Weekly Report · 11/02 10:24
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Seeking Alpha · 10/29 19:44
Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones · 10/28 11:49
HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target
Benzinga · 10/28 11:39
Weekly Report: what happened at CNTB last week (1019-1023)?
Weekly Report · 10/26 10:24
Here's Why Connect Biopharma Holdings (CNTB) Could be Great Choice for a Bottom Fisher
NASDAQ · 10/19 12:55
Weekly Report: what happened at CNTB last week (1012-1016)?
Weekly Report · 10/19 10:24
Connect Biopharma Price Target Announced at $4.00/Share by Leerink Partners
Dow Jones · 10/12 12:37
Connect Biopharma Coverage Assumed by Leerink Partners at Outperform
Dow Jones · 10/12 12:37
Leerink Partners Assumes Connect Biopharma Hldgs at Outperform, Announces Price Target of $4
Benzinga · 10/12 12:27
Leerink Partners Sticks to Their Buy Rating for Connect Biopharma Holdings (CNTB)
TipRanks · 10/12 11:36
Connect Biopharma assumed with an Outperform at Leerink
TipRanks · 10/12 11:15
Weekly Report: what happened at CNTB last week (1005-1009)?
Weekly Report · 10/12 10:30
Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones · 10/08 11:06
HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target
Benzinga · 10/08 10:56
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)
TipRanks · 10/08 10:30
Weekly Report: what happened at CNTB last week (0928-1002)?
Weekly Report · 10/05 10:29
Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures
NASDAQ · 10/04 07:02
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
TipRanks · 10/02 11:00
More
Webull provides a variety of real-time CNTB stock news. You can receive the latest news about Connect Biopharma Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.